Vicarious Surgical Inc. Stock News

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficien

Is this stock the next Intuitive Surgical? Maybe. We won't know for sure, though, until it has something to sell.

Vicarious Surgical, Inc. (NYSE:RBOT ) Q4 2022 Earnings Conference Call February 13, 2023 4:30 PM ET Company Participants Kaitlyn Brosco - IR Adam Sachs - Co-Founder, CEO, President & Director William

WALTHAM, Mass.--( BUSINESS WIRE )--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, effici

WALTHAM, Mass.--( BUSINESS WIRE )--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, effici

Vicarious Surgical Inc. (NYSE:RBOT ) Q3 2022 Earnings Conference Call November 7, 2022 4:30 PM ET Company Participants Kaitlyn Brosco - Director, Investor Relations Adam Sachs - Co Founder & CEO Bill

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient

Vicarious Surgical Inc. (NYSE:RBOT ) Q2 2022 Earnings Conference Call August 8, 2022 4:30 PM ET Company Participants Kaitlyn Brosco - Director, Investor Relations Adam Sachs - Chief Executive Officer

Although equities just finished one of the worst first-half performances ever, it also opened doors to the best bargain stocks to buy. The post 7 Best Bargain Stocks to Buy in July 2022 appeared first

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient

Vicarious Surgical Inc. (NYSE:RBOT ) Q1 2022 Earnings Conference Call May 9, 2022 4:30 PM ET Company Participants Marissa Bych - Gilmartin Group Adam Sachs - Co Founder & Chief Executive Officer Bill

Piper Sandler has downgraded Vicarious Surgical Inc (NASDAQ: RBOT) to Neutral from Overweight with a price target of $7, down from $16, below expected Q4 results.  A majority of the earnings call

Vicarious Surgical Inc. (RBOT) CEO Adam Sachs on Q4 2021 Results - Earnings Call Transcript

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient

Robotics Investments In December 2021